Publications by authors named "Ruth Coll"

Claim this Profile
E
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
Richard B Warren, Marjolein de Bruin-Weller, Athanasios Tsianakas, Abdallah Khemis, Jacek C Szepietowski, Ruth Coll

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft.
Daniel Chaverri, Santiago Gallardo-Villares, Javier A Pinto, Luciano Rodríguez, Margarita Codinach, Ruth Coll

Injury· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting.
Ahmet Fuat, Ella Adlen, Mark Monane, Ruth Coll, Sarah Groves

Eur J Prev Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of allogeneic eye drops from cord blood platelet lysate.
Dinara Samarkanova, Sara Martin, Laia Bisbe, Javier Puig, Marta Calatayud-Pinuaga, Ruth Coll

Blood Transfus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
Joan Garcia-Lopez, Joaquin Delgadillo, Anna Vilarrodona, Sergi Querol, Joan Ovejo, Ruth Coll

Blood Transfus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
Sergiu Albu, Hatice Kumru, Ruth Coll, Joaquim Vives, Margarita Vallés

Cytotherapy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience.
Paloma Gastelurrutia, Cristina Prat-Vidal, Joaquim Vives, Ruth Coll, Antoni Bayes-Genis

Front Cardiovasc Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore, Leonard G Gomella, Ruth Coll

Lancet Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application.
Dinara Samarkanova, Luciano Rodríguez, Joaquim Vives, Ruth Coll, Elisabet Tahull

Blood Transfus· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.
Cristina Prat-Vidal, Luciano Rodríguez-Gómez, Miriam Aylagas, Nuria Nieto-Nicolau, Paloma Gastelurrutia, Ruth Coll

EBioMedicine· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis.
Salvi Prat, Santiago Gallardo-Villares, Marian Vives, Ana Carreño, Marta Caminal, Ruth Coll

J Tissue Eng Regen Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of a phase I-II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration.
Robert Soler, Lluis Orozco, Ana Munar, Marina Huguet, Ramon López, Ruth Coll

Knee· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.
Luigi Gugliotta, Carlos Besses, Martin Griesshammer, Claire Harrison, Jean-Jacques Kiladjian, Ruth Coll

Haematologica· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study.
Carlos Besses, Jean-Jacques Kiladjian, Martin Griesshammer, Luigi Gugliotta, Claire Harrison, Ruth Coll

Leuk Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS study.
Jean-Jacques Kiladjian, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire Harrison, Ruth Coll

Clin Drug Investig· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tolerability of anagrelide hydrochloride in young (18 - 50 years) and elderly (≥ 65 years) patients with essential thrombocythemia.
Carlos Besses, Wolfgang Zeller, Alberto Alvarez-Larrán, Ruth Coll, Steven Troy

Int J Clin Pharmacol Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis